Skip to main content
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Psychopharmacology
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
CME: I Love Muscarinic Control! Targeting the Muscarinic System in the Treatment of Schizophrenia
End of the Anticholinergic Era? Breaking Down the Anticholinergic System: Risks and Realities (Module 1)
CME: Psychopharmacolojourney: A Look at How Far We Have Come and Where We Might Go
Schizophrenia Unfiltered, Part 3: Pathways to Novel Treatment
Ins and Outs of Antipsychotic Therapy for Schizophrenia
End of the Anticholinergic Era? Rationale and Evidence-Based Strategies for Deprescribing
The Next Generation of Schizophrenia Treatment: Looking Beyond D2 and Exploring Novel Therapeutic Targets
Overcoming Challenges in Schizophrenia Treatment
New Mechanisms of Action in Psychiatry
Developments in Treating Schizophrenia: New Mechanisms of Action and Methods of Delivery
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Next page
Next ›
Last page
Last »